about
Neurotrophic factors in Alzheimer’s disease: role of axonal transportTemperature and toxic Tau in Alzheimer's disease: new insightsMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesAlzheimer's Disease: Mechanism and Approach to Cell TherapyGenetic variants associated with neurodegenerative Alzheimer disease in natural modelsPACSIN1, a Tau-interacting protein, regulates axonal elongation and branching by facilitating microtubule instabilityHDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytesTau-mediated synaptic damage in Alzheimer's diseaseThree-repeat Tau 69 is a major tau isoform in laser-microdissected Pick bodies.Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics.Roles of tau protein in health and disease.Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable mannerStructure and pathology of tau protein in Alzheimer disease.NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease.Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.Tau PET imaging: present and future directions.Splicing factor SC35 promotes tau expression through stabilization of its mRNA.GSK3 and Alzheimer's Disease: Facts and Fiction….Overexpression of tau downregulated the mRNA levels of Kv channels and improved proliferation in N2A cells.Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.Regulation of human MAPT gene expression.Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.The role of tau in the pathological process and clinical expression of Huntington's diseaseA Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregationThe microtubule-associated protein tau is phosphorylated by SykThe genetics of neurodegenerative diseases.Tau exon 10 alternative splicing and tauopathiesThe complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle.Looking for novel ways to treat the hallmarks of Alzheimer's disease.Phosphopeptide enrichment with TiO2-modified membranes and investigation of tau protein phosphorylation.Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.
P2860
Q22242329-AC188238-2D4E-4A6D-89FE-C5F4A1583318Q26745778-BEE81D49-C029-46AC-94D9-124546D65D70Q26768648-510CBE60-9642-4636-A62E-BE041FDB7BACQ26769957-07A51B77-CD89-44A8-8B8E-BD961BF2BCE2Q26778149-D7B32546-1071-40E8-A59B-8D847E888594Q28079843-EF0620D2-2859-4ECB-81DC-227CFDEB34B6Q28574383-B9BD3C63-7ABF-4BEA-BBD1-69AAA5EFE209Q28575023-0B2CC10B-C636-4CDA-A0DC-5368EC4FB033Q28831067-B7E72C1E-BB22-44A6-AD08-94FEC7F721E4Q33243165-5CB7230D-830D-4C4C-9A88-15B209E8488AQ33490153-4DBE5507-D185-4B94-9CCA-326A87A001AEQ33559303-0DECC27F-9113-4A3B-A124-BA11D34A0C86Q33822354-6313FD2D-A909-4563-95CB-54BDCE334138Q33861397-80296426-DD8E-431F-B12A-EEF08E2D9648Q34035745-856CFEF8-272E-42D2-A8EF-82294BC98FD5Q34280787-94A3F923-6E42-4311-A5A4-C8A10C881459Q34479707-30ECF3DD-9AA1-401B-802A-56FC56AB0982Q34610487-B25421A7-2E10-44F9-80FA-08FFFE93ACE4Q34659234-AC7B64FD-9EB6-4049-94DF-33BD69005BB9Q34680852-528D425C-78F9-4A8C-A0C6-AEE8E7542607Q34764464-306461C0-4C5D-438F-8A4A-F48DB0F005B6Q35182282-5F99CC08-9D06-48C2-9E4F-D51CEC4231C6Q35543023-56017631-D9A7-47B4-AE26-FFB0B16C9C7EQ35575041-EB1EEEA1-A173-4CB0-9EBC-8AF4F018E809Q35747174-8CAFE7AA-3FE2-4A98-9B7A-2608EBA05312Q35844758-1A200F35-1D10-4B7F-8409-C875FB949D87Q35938561-74615B6F-7FBB-438F-BEC9-721386A35D48Q36012068-C634253E-68A2-4545-8C5B-19207554EEABQ36066666-803EEAB7-DEA1-4C1D-B57E-03D53881A276Q36167192-600467CE-8F25-40BE-92A6-A3CC5A3F4672Q36251998-57F0C0AE-D6F4-413B-B65B-E41D323DEAE5Q36454890-F0073880-4612-4E7F-B6A0-43AF1708ED02Q36482397-4AC7D90C-F8BB-4556-91B7-7CC7BA793747Q36521941-40794510-092C-4227-B15E-14A1C646780BQ36789895-4E998690-3052-418A-92D7-9E6E15B4118AQ36850209-1980C136-C2C5-43A7-9626-65FC12291B97Q36904846-7180706C-7D07-4CC7-BDCA-299D4D407C42Q37040466-E2063A20-8107-4A4E-8153-3C19ACD4C94EQ37053945-72B57CCF-1B1C-4135-B7D5-EA54D8C3F5AFQ37060457-8FAAF255-CDA8-4459-8443-CC574EBB2F50
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tau protein as a differential biomarker of tauopathies.
@ast
Tau protein as a differential biomarker of tauopathies.
@en
type
label
Tau protein as a differential biomarker of tauopathies.
@ast
Tau protein as a differential biomarker of tauopathies.
@en
prefLabel
Tau protein as a differential biomarker of tauopathies.
@ast
Tau protein as a differential biomarker of tauopathies.
@en
P2093
P1476
Tau protein as a differential biomarker of tauopathies.
@en
P2093
André Delacourte
Nicolas Sergeant
P304
P356
10.1016/J.BBADIS.2004.06.020
P407
P577
2005-01-01T00:00:00Z